Compare SUN & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | DVA |
|---|---|---|
| Founded | 1886 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Misc Health and Biotechnology Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 8.2B |
| IPO Year | N/A | 1995 |
| Metric | SUN | DVA |
|---|---|---|
| Price | $57.55 | $140.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $65.00 | ★ $156.75 |
| AVG Volume (30 Days) | 464.3K | ★ 1.4M |
| Earning Date | 02-17-2026 | 02-02-2026 |
| Dividend Yield | ★ 6.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.93 | ★ 9.84 |
| Revenue | ★ $21,870,000,000.00 | $13,643,069,000.00 |
| Revenue This Year | $11.09 | $3.37 |
| Revenue Next Year | $46.49 | $3.67 |
| P/E Ratio | $19.87 | ★ $15.17 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $47.98 | $101.00 |
| 52 Week High | $59.88 | $178.47 |
| Indicator | SUN | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 85.03 |
| Support Level | $56.80 | $105.41 |
| Resistance Level | $58.49 | $110.43 |
| Average True Range (ATR) | 1.23 | 4.59 |
| MACD | -0.15 | 5.44 |
| Stochastic Oscillator | 31.23 | 98.68 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.